Term
characteristics of a good topical drug? 4 |
|
Definition
low molecular mass adequate solubility in lipid and water high partition coefficient hydrated corneum |
|
|
Term
4 abnormalities leading to acne. |
|
Definition
Hyperkeratinization (caused by androgens Sebum production (increased by androgens) Bacteria (p. acnes) produces lipase to form FFA Inflammatory - FFA cause immune response |
|
|
Term
Name some environmental factors that can increase acne |
|
Definition
mechanical irritants such as helmets and headbands. Occlusive materials such as lotions and cosmetics that are oil based |
|
|
Term
benzoyl peroxide MOA? Uses? SE? |
|
Definition
keratolytic via solubilizing cell surface proteins. Bacteriocidial - generates free radicals to kill P. acnes Comedolytic - results from keratolytic features Use - Acne. often included w/ erythromycin or clindamycin SE - irritation, erythema, bleaching, or rarely contact dermatitis |
|
|
Term
|
Definition
only keratolytic via solubilizing intercellular adhesion proteins SE - irritation, erythema, rare salicylism |
|
|
Term
Topical Sulfur compounds MOA SE |
|
Definition
keratolytic and desquamative SE - skin staining, rotten egg odor, and comedogenic w/ long term use |
|
|
Term
|
Definition
inhibits DNA synthesis in bacteria, scavenges free radicles (anti-inflammatory), and keratolytic SE - irritation, itching, HYPOPIGMENTATION. |
|
|
Term
|
Definition
steroid type drug that binds to RARs and RXRs in nucleus, dimerize, and bind to promoters. Binds and regulates cellular proliferation and differentiation RAR --> therapeutic effects RXRs --> SEs. |
|
|
Term
|
Definition
Binds to RARs --> exfoliative via increasing turnover. decreases cell adhesion. Prevents new comedone formation SE - peeling, dryness, "appearance" of worse acne, degrades in UV light --> worse SE (thus apply at night Also has anti-wrinkle effect via vasodilation and increase collagen |
|
|
Term
|
Definition
designed for acne to specifically target pilosebacious units. Binds to RARs. SE - same as tretinoin but less severe. |
|
|
Term
|
Definition
prodrug converted to active via esterases --> exfoliative via promoting cellular differentiation by blocking ornithine decarboxylase. Also anti-inflammatory. SE - same as tretinoin. category X |
|
|
Term
|
Definition
all cis retinoic acid. Given orally Corrects all 4 abnormalities in acne. Has the best results of any drug. SE - common: dry skin, pruritis, dry eyes, alopecia. Serious: IBD, worsening lipid profile, psychological (depression/suicide), highly sunlight sensitive, category X, pseudotumor cerebri w/ tetracyclins. |
|
|
Term
Erythromycin Route of administration MOA SE |
|
Definition
macrolide antibiotic. Topical and systemic MOA - inhibits translocation via binding of the 50s ribosome SE - liver enzyme inhibitor |
|
|
Term
Clindamycin route of administration MOA SE |
|
Definition
not a macrolide. Topical and systemic MOA - inhibits protein synthesis via binding to 50s ribosome and inhhibiting translocation and peptidyl transferase SE - pesudomembranous colitis. |
|
|
Term
tetracycline route of administration MOA SE |
|
Definition
topical or systemic MOA - inhibits translation of mRNA into proteins via binding 30s ribosome SE - alters normal intestinal flora, binds to calcium -> tooth/bone effects. Decreased absorption when used w/ antacids, dairy, and iron. Photosensitization. |
|
|
Term
Doxycycline Route of administration MOA SE |
|
Definition
only systemically given MOA - same as tetracyclin SE - increased incidence of all the tetracycline side effects |
|
|
Term
Minocycline route of administration MOA SE |
|
Definition
systemic only MOA - same as tetracycline SE - same as tetracycline w/ lower incidence. May develop ototoxicity (vestibular effects) |
|
|
Term
|
Definition
increase sex hormone binding globulin -> decreased free testosterone --> decreased sebum and hyperkeratinization. 2-4 months for results SE - promotes clotting, MI in smokers, stroke, breast cancer. Relapse upon stopping |
|
|
Term
|
Definition
autoimmune activated Th1 cells are re-activated by APCs in the dermis -> psoriatic plaque from chemokines released affecting keratinocytes. lack of Th17 (Treg) also contribute. Triggered by infection, drugs, trauma, UV light, hypocalcemia. Very high cell turnover rate. thick plaques, capillary dilation --> redness, neutrophil/lymphocyte infiltration, |
|
|
Term
Psoriasis What drugs used to treat? |
|
Definition
emollients and keratolytics - salicylic acid. Immunosuppresants - corticosteroids, cyclosporine A, alefacept, adilimumab, stelara (ustekinumab), vit d, retinoids, methotrexate. |
|
|
Term
|
Definition
bind to cytoplasmic glucocorticoid receptors and releases HSP 90. Translates to nucleus and binds to GRE to suppress inflammatory genes (IL-1,2,6) and upregulate anti-inflammatory genes. Very High potency flourinated GCs should not be used on the face. SEs - potential to suppress HPA axis. Iatrogenic cushings. Topical used may cause purpura, rosacea, dermatitis, skin atrophy |
|
|
Term
|
Definition
binds to cyclophilin to become a calcineurin inhibitor that stops transcription of NF-AT -> no IL-2 production -> no T cell activation SE - nephrotoxic (additive w/ other drugs. ex. statins), HTN, and hirsutism |
|
|
Term
|
Definition
MOA - interferes w/ APC interaction -> reduction of activated lymphocytes Use - moderate to severe plaque psoriasis SE - CD4 lymphocyte count can drop (monitor the levels). Discontinue if below 250. |
|
|
Term
|
Definition
monoclonal humanized antibody MOA - binds plasma membrane bound TNF-a --> lysis of T-cells SE - allergic reactions, lymphoma, susceptible to infections (r/o TB before prescribing) |
|
|
Term
|
Definition
a retinoid. Prodrug converted to etritinate. MOA - not known but normalizes growth of keratinocytes Use - moderate to severe psoriasis SE - similar to isoretinoin, more teratogenic, very fat soluble -> wait to donate blood or get pregnant. |
|
|
Term
|
Definition
MOA - antipruritic properites via phenolic compounds. epidermal hyperplasia followed by sytostatic effect and epidermal thinning. Use - psoriasis, dermatitis, lichen simplex chronicus SE - irritant, odor, phototoxicity |
|
|
Term
|
Definition
MOA - vit d3 analog. ointment. inhibits keratinocyte differentation and proliferation via decreasing Th1 stimulating cytokines (IL-2) Use - moderate plaque psoriasis SE - burning, itching, avoid mucous membranes (esp eyes), transient hypercalcemia |
|
|
Term
Methotrexate use in psoriasis. SE? |
|
Definition
affects the rapidly dividing cells. beneficial via anti-inflammatory effects from decreased IL-1 production and death of active T cells. SE - hepatic fibrosis, protein bound, BM suppression, megaloblastic anemia |
|
|
Term
|
Definition
UVB - often used first. short wavelength. Can be combined w/ other agents PUVA - long wavelength, can cause skin cancer, need to use psoralen |
|
|
Term
|
Definition
facilitates GABA and inhibits NMDA. Depresses cardiac contractility Relaxes fascular smooth muscle, uterine smooth muscle, hypothermia FAEE cause baby problems and cardiac fibrosis. detected in meconium cross tolerance to benzo and barbituates pancreatitis, peripheral neuropathies, gynectomastia, testes atrophy, edema |
|
|
Term
|
Definition
lowers activity of receptors for glutamate. Used to maintain abstinence. |
|
|
Term
|
Definition
inhibit NE, dopa, and serotonin reuptake. mixed with alcohol causes resp depression, MI. Cocaethylene causes hep failure, resp depression, stops ox phos, CV collapse. ingested --> severe bowel gangrene fetal complications - abortion, tremors, suckling failure, mental retard, visual probs, rupture of membranes, preterm, IUGR, abruptio placentae |
|
|
Term
|
Definition
releases dopa and NE, rapid pulse, bronchial passage relaxation.more frequent lung infection, can produce anxiety, fear, panic. hands tremble. impairs memory, recal, attention. |
|
|
Term
|
Definition
rapid emotional swings. Stimulates pre and post synaptic serotonin receptors |
|
|
Term
|
Definition
pupillary dilation. Increased blood pressure, hyperreflexia |
|
|
Term
Name 3 dissociative agents |
|
Definition
PCP (phencyclidine) and ketamine, dextromethorphan |
|
|